Urinary metabolites of cannabidiol in dog, rat and man and their identification by gas chromatography-mass spectrometry.
Urinary metabolites of cannabidiol (CBD), a non-psychoactive cannabinoid of potential therapeutic interest, were extracted from dog, rat and human urine, concentrated by chromatography on Sephadex LH-20 and examined by gas chromatography-mass spectrometry as trimethylsilyl (TMS), [2H9]TMS, methyl ester-TMS and methyloxime-TMS derivatives. Fragmentation of the metabolites under electron-impact gave structurally informative fragment ions; computer-generated single-ion plots of these diagnostic ions were used extensively to aid metabolite identification. Over fifty metabolites were identified with considerable species variation. CBD was excreted in substantial concentration in human urine, both in the free state and as its glucuronide. In dog, unusual glucoside conjugates of three metabolites (4"- and 5"-hydroxy- and 6-oxo-CBD), not excreted in the unconjugated state, were found as the major metabolites at early times after drug administration. Other metabolites in all three species were mainly acids. Side-chain hydroxylated derivatives of CBD-7-oic acid were particularly abundant in human urine but much less so in dog. In the latter species the major oxidized metabolites were the products of beta-oxidation with further hydroxylation at C-6. A related, but undefined pathway resulted in loss of three carbon atoms from the side-chain of CBD in man with production of 2"-hydroxy-tris,nor-CBD-7-oic acid. Metabolism by the epoxide-diol pathway, resulting in dihydro-diol formation from the delta-8 double bond, gave metabolites in both dog and human urine. It was concluded that CBD could be used as a probe of the mechanism of several types of biotransformation; particularly those related to carboxylic acid metabolism as intermediates of the type not usually seen with endogenous compounds were excreted in substantial concentration.
Harvey
D J
DJ
University Department of Pharmacology, Oxford, U.K.
Samara
E
E
Mechoulam
R
R
D000535:Aluminum; D017607:Aluminum Compounds; D000818:Animals; D002185:Cannabidiol / Q000652:urine*; D002849:Chromatography, Gas; D003903:Deuterium; D004285:Dogs; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D008094:Lithium; D018020:Lithium Compounds; D008297:Male; D051381:Rats; D013045:Species Specificity; D014297:Trimethylsilyl Compounds / Q000378:metabolism
D017607:Aluminum Compounds; D018020:Lithium Compounds; D014297:Trimethylsilyl Compounds; D002185:Cannabidiol; C042073:lithium aluminum hydride; D008094:Lithium; D003903:Deuterium; D000535:Aluminum